What is the acute management of febrile status epilepticus in a child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Febrile Status Epilepticus in Children

Immediate Stabilization and First-Line Treatment

Begin with airway, breathing, and circulation assessment, provide high-flow oxygen, check blood glucose, and immediately administer lorazepam 0.1 mg/kg IV (maximum 2 mg) as first-line treatment, repeating after at least 1 minute if seizures persist (maximum 2 doses). 1

  • Position the child on their side, remove harmful objects, and protect the head from injury 2
  • Never restrain the patient or place anything in the mouth during active seizure activity 2
  • Transfer immediately to the pediatric intensive care unit (PICU) for convulsive status epilepticus 1
  • The median time from seizure onset to first antiepileptic drug (AED) administration is typically 30 minutes, but earlier treatment significantly reduces total seizure duration 3

Second-Line Treatment

If seizures persist after benzodiazepines, immediately administer levetiracetam 40 mg/kg IV bolus (maximum 2,500 mg) in addition to maintenance dosing. 1

  • This should be given concurrently with the benzodiazepine protocol, not sequentially 1
  • Febrile status epilepticus rarely stops spontaneously and is fairly resistant to medications, with mean seizure duration of 81-95 minutes even with treatment 3

Third-Line Treatment for Refractory Seizures

Add phenobarbital IV at a loading dose of 10-20 mg/kg (maximum 1,000 mg) if seizures persist despite benzodiazepines and levetiracetam. 1

  • Approximately 70% of children with febrile status epilepticus require more than one AED to terminate seizures 3
  • The median time from first AED dose to seizure termination is 38 minutes 3
  • Continuous EEG monitoring is essential if seizures remain refractory 1

Respiratory Support

  • Anticipate the need for respiratory support in approximately 48% of cases 3
  • Children requiring respiratory support have significantly longer seizure duration (median 83 minutes vs. 58 minutes without support, p<0.001) 3
  • This reflects seizure severity rather than treatment complications 3

Maintenance Therapy After Seizure Termination

Following resolution of status epilepticus, administer maintenance doses: 1

  • Lorazepam 0.05 mg/kg (maximum 1 mg) IV every 8 hours for 3 doses 1
  • Levetiracetam 30 mg/kg IV every 12 hours or increase prophylaxis dose by 10 mg/kg (to 20 mg/kg) IV every 12 hours (maximum 1,500 mg) 1
  • Phenobarbital 1-3 mg/kg IV every 12 hours if used 1

Critical Pitfalls to Avoid

  • Suboptimal initial benzodiazepine dosing occurs in 19% of cases—ensure weight-based dosing is accurate 3
  • Do not delay treatment waiting for IV access; earlier onset of treatment results in significantly shorter total seizure duration 3
  • The total seizure duration comprises two factors: time from onset to AED initiation and time from first AED to termination—reducing the first interval is critical 3

Long-Term Prognosis and Follow-Up

  • Acute hippocampal injury (visible as T2 hyperintensity on MRI) occurs in approximately 10% of febrile status epilepticus cases 4
  • Children with acute hippocampal T2 hyperintensity have a 71% 10-year cumulative incidence of epilepsy and 39% risk of medial temporal lobe epilepsy 4
  • Those with completely normal acute MRI have only 23% epilepsy risk and essentially no risk of temporal lobe epilepsy 4
  • Neurologically normal children who experience febrile status epilepticus do not have significantly increased risk for subsequent febrile or afebrile seizures compared to brief febrile seizures 5
  • However, neurologically impaired children with febrile status epilepticus have 66% risk of recurrent febrile seizures and 33% risk of recurrent febrile status epilepticus 5

Special Consideration: FIRES (Febrile Infection-Related Epilepsy Syndrome)

  • If refractory status epilepticus develops 24 hours to 2 weeks after a febrile illness, consider FIRES—a distinct entity requiring immunomodulatory treatment including ketogenic diet, IV corticosteroids, and IV immunoglobulin 6, 7
  • FIRES has poor prognosis with significant cognitive disability and refractory epilepsy 6

Post-Acute Management

Do NOT prescribe continuous or intermittent anticonvulsant prophylaxis for simple or complex febrile seizures following resolution of status epilepticus, as the risks clearly outweigh benefits. 2, 8

  • Antipyretics (acetaminophen, ibuprofen) should be used for comfort only, not seizure prevention, as they do not reduce recurrence risk 2, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pediatric Seizure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Febrile status epilepticus.

Pediatrics, 1990

Research

Febrile Infection-Related Epilepsy Syndrome (FIRES): An Overview of Treatment and Recent Patents.

Recent patents on inflammation & allergy drug discovery, 2018

Guideline

Febrile Seizures: Risk of Epilepsy and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.